Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension

Hypertension
T HrafnkelsdóttirS Jern

Abstract

We have shown that the capacity for local release of tissue-type plasminogen activator (tPA) from the vascular endothelium is impaired in patients with primary hypertension. Because this response is an important protective mechanism against intravascular clotting, we investigated whether this system is also defective in patients with advanced chronic kidney disease and hypertension. Nine nondiabetic nonsmoking men with chronic kidney disease (glomerular filtration rate 11 to 28 mL/min x 1.73 m2; aged 33 to 75 years) were compared with age-matched healthy controls. Intraarterial infusions of desmopressin, methacholine, and sodium nitroprusside were given locally in the brachial artery. Forearm blood flow was measured by venous occlusion plethysmography and blood collected repeatedly during the desmopressin infusion for determination of stimulated net and total cumulated release of tPA. The maximal release rate of active tPA (P<0.05) and the capacity for acute tPA release were markedly impaired in the renal patients as compared with healthy subjects (ANOVA, P=0.013). Accordingly, the accumulated release of tPA was 1905 (SEM 366) and 3387 (718) ng/L tissue, respectively (P<0.05). However, there were no significant differences in v...Continue Reading

References

Nov 10, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G M LondonA P Guerin
Feb 7, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M AnnukB Fellström
Feb 24, 2001·International Journal of Clinical & Laboratory Research·A CupistiG Barsotti
Jul 4, 2002·The Journal of Physiology·Christopher A DeSouzaBrian L Stauffer
May 1, 1964·Journal of Clinical Pathology·N EDWARDM MACLEOD

❮ Previous
Next ❯

Citations

May 27, 2011·Journal of Thrombosis and Thrombolysis·Wilhelm RidderstråleThórdís J Hrafnkelsdóttir
Dec 12, 2012·Journal of Thrombosis and Thrombolysis·Pia LarssonSverker Jern
Jan 1, 2012·Cardiovascular Intervention and Therapeutics·Makoto Furugen, Yoshitoki Takagawa
Dec 1, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Varun AgrawalPeter A McCullough
Jul 28, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Gagan KumarUNKNOWN Milwaukee Initiative in Critical Care Outcomes Research (MICCOR) Group of Investigators
Oct 11, 2012·European Heart Journal·Sumeet SharmaDiana A Gorog
May 26, 2012·Canadian Journal of Physiology and Pharmacology·Chris R TriggleHong Ding
Jul 9, 2005·Journal of Hypertension·Erik UlfhammerSverker Jern
Nov 26, 2015·Nature Reviews. Nephrology·Thati MadhusudhanBerend Isermann
Jun 12, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Khai P NgCharles J Ferro
May 3, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Nauman TariqAdnan I Qureshi
Oct 23, 2015·The Journal of Trauma and Acute Care Surgery·Michael P ChapmanChristopher C Silliman
Apr 4, 2007·Journal of Thrombosis and Haemostasis : JTH·K JoodT Hrafnkelsdóttir
May 16, 2006·Bipolar Disorders·Max Fink
Nov 26, 2008·Acta Anaesthesiologica Scandinavica·B OsterlundB Biber
Oct 9, 2014·PloS One·Ott SaluveerNiklas Bergh
Feb 2, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Soon-Ki MinJong-Ki Kim
Sep 24, 2016·Journal of the American College of Cardiology·Yee C LauGregory Y H Lip
Jan 29, 2016·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Aslak RautioMaria K Svensson
Nov 11, 2017·Journal of the American Heart Association·Brian L StaufferChristopher A DeSouza
Mar 8, 2006·Hypertension·Wilhelm RidderstråleThórdís Hrafnkelsdóttir
Oct 8, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·James J OliverDavid E Newby
Mar 9, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Andrew J LuckingDavid E Newby
Jan 27, 2007·Stroke; a Journal of Cerebral Circulation·Georgios TsivgoulisUNKNOWN CLOTBUST Investigators
Jul 15, 2016·American Journal of Physiology. Renal Physiology·Kunyu ShenGlenda C Gobe
Aug 26, 2021·Stroke; a Journal of Cerebral Circulation·Georgios TsivgoulisAndrei V Alexandrov
Dec 17, 2009·Stem Cells·Josephine B AllenGuillermo A Ameer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.